Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
Inspire Medical Systems (NYSE: INSP) has scheduled its first quarter 2025 financial results release for Monday, May 5, 2025, after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss the quarterly results and recent business developments.
The earnings call will be accessible through two options: a webcast via the company's Investor Relations page for listeners, and a separate registration link for participants planning to ask questions. Participants are advised to register at least 10 minutes before the call. A replay will be available on the Investor Relations website approximately two hours after the event and will be archived for two weeks.
Inspire Medical Systems (NYSE: INSP) ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per lunedì 5 maggio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 17:00, ora orientale, per discutere i risultati trimestrali e gli sviluppi aziendali recenti.
La chiamata sugli utili sarà accessibile attraverso due opzioni: un webcast tramite la pagina delle Relazioni con gli Investitori dell'azienda per gli ascoltatori, e un link di registrazione separato per i partecipanti che intendono porre domande. Si consiglia ai partecipanti di registrarsi almeno 10 minuti prima della chiamata. Una registrazione sarà disponibile sul sito web delle Relazioni con gli Investitori circa due ore dopo l'evento e sarà archiviata per due settimane.
Inspire Medical Systems (NYSE: INSP) ha programado la publicación de sus resultados financieros del primer trimestre de 2025 para el lunes 5 de mayo de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica a las 5:00 p.m., hora del Este, para discutir los resultados trimestrales y los recientes desarrollos comerciales.
La llamada de ganancias será accesible a través de dos opciones: un webcast a través de la página de Relaciones con Inversores de la compañía para los oyentes, y un enlace de registro separado para los participantes que planean hacer preguntas. Se aconseja a los participantes registrarse al menos 10 minutos antes de la llamada. Una repetición estará disponible en el sitio web de Relaciones con Inversores aproximadamente dos horas después del evento y se archivará durante dos semanas.
Inspire Medical Systems (NYSE: INSP)는 2025년 1분기 재무 결과 발표를 2025년 5월 5일 월요일, 시장 종료 후로 예정하고 있습니다. 회사는 동부 표준시 기준 오후 5시에 분기 결과 및 최근 사업 개발에 대해 논의하기 위해 컨퍼런스 콜을 개최할 것입니다.
실적 발표 전화는 두 가지 옵션을 통해 접근할 수 있습니다: 청취자를 위한 회사의 투자자 관계 페이지를 통한 웹캐스트와 질문을 할 계획인 참가자를 위한 별도의 등록 링크입니다. 참가자는 전화 시작 10분 전까지 등록하는 것이 좋습니다. 이벤트 후 약 2시간 후에 투자자 관계 웹사이트에서 재생이 가능하며, 2주 동안 아카이브됩니다.
Inspire Medical Systems (NYSE: INSP) a prévu la publication de ses résultats financiers pour le premier trimestre 2025 pour le lundi 5 mai 2025, après la clôture du marché. L'entreprise organisera une conférence téléphonique à 17h00, heure de l'Est, pour discuter des résultats trimestriels et des développements récents de l'entreprise.
L'appel sur les résultats sera accessible par deux options : un webinaire via la page des Relations avec les Investisseurs de l'entreprise pour les auditeurs, et un lien d'inscription séparé pour les participants prévoyant de poser des questions. Il est conseillé aux participants de s'inscrire au moins 10 minutes avant l'appel. Un enregistrement sera disponible sur le site Web des Relations avec les Investisseurs environ deux heures après l'événement et sera archivé pendant deux semaines.
Inspire Medical Systems (NYSE: INSP) hat die Veröffentlichung der finanziellen Ergebnisse für das erste Quartal 2025 auf Montag, den 5. Mai 2025, nach Börsenschluss angesetzt. Das Unternehmen wird um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Quartalsergebnisse und aktuelle Geschäftsentwicklungen zu besprechen.
Der Gewinnanruf wird über zwei Optionen zugänglich sein: ein Webcast über die Investor-Relations-Seite des Unternehmens für Zuhörer und einen separaten Registrierungslink für Teilnehmer, die Fragen stellen möchten. Teilnehmer werden gebeten, sich mindestens 10 Minuten vor dem Anruf zu registrieren. Eine Wiederholung wird etwa zwei Stunden nach der Veranstaltung auf der Investor-Relations-Website verfügbar sein und für zwei Wochen archiviert werden.
- None.
- None.
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q1 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
